Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

British Journal of Clinical Pharmacology
J A MillarJ L Reid


No abstract listed.


Jul 5, 1979·The New England Journal of Medicine·N K HollenbergG H Williams
Feb 1, 1975·Life Sciences·D P HenryR H Williams
Jul 1, 1971·Biochemical Pharmacology·D W Cushman, H S Cheung
Nov 20, 1980·Nature·A A PatchettC A Stone
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·P I Korner
Mar 19, 1955·British Medical Journal·E P SHARPEY-SCHAFER


Jan 1, 1986·European Journal of Clinical Pharmacology·A A AjayiJ L Reid
Jan 1, 1986·European Journal of Clinical Pharmacology·B A van SchaikE J Mees
Jan 1, 1987·Cardiovascular Drugs and Therapy·I L Natoff
Jan 1, 1987·Cardiovascular Drugs and Therapy·P F SempleJ J Morton
Oct 21, 1983·Pharmaceutisch Weekblad. Scientific Edition·P A Van ZwietenP B Timmermans
Apr 27, 2002·Journal of Clinical Pharmacy and Therapeutics·M RouiniA Ismailpour
Aug 1, 1990·British Journal of Clinical Pharmacology·J GeneveC Caulin
May 1, 1992·Clinical and Experimental Pharmacology & Physiology·S MinatoguchiH Majewski
May 17, 2003·Drugs & Aging·Kourosh MoazemiAbraham G Kocheril
Jan 1, 1987·European Journal of Clinical Pharmacology·B A van SchaikP Boer
Jan 1, 1988·European Journal of Clinical Pharmacology·B A van SchaikA J Porsius
Jan 1, 1989·Journal of Toxicology. Clinical Toxicology·H A SpillerS Muir
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·R G AsmarM E Safar
Oct 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J H Bauer, P Gaddy
Jul 10, 2010·Journal of Renal Care·David BenaventeCharles J Ferro
Dec 1, 1987·British Journal of Clinical Pharmacology·P H SeidelinA D Struthers
Apr 1, 1983·British Journal of Clinical Pharmacology·A W KelmanJ A Millar
Mar 1, 1988·Clinical and Experimental Dermatology·R J Barlow, E J Schulz
Feb 1, 1987·British Journal of Clinical Pharmacology·K R Lees, J L Reid
Jan 1, 1989·British Journal of Clinical Pharmacology·A H ThomsonB Whiting
Apr 24, 1987·The American Journal of Cardiology·S G Ball, J I Robertson
Oct 8, 1992·The American Journal of Cardiology·F ZannadM Bory
Apr 1, 1989·Angiology·E L KinneyJ W Caldwell
Jan 1, 1984·The American Journal of Cardiology·H H RotmenschR K Ferguson
Jun 13, 2020·Pharmaceutics·Panagiotis KanellopoulosTheodosia Maina
Apr 1, 1986·British Journal of Clinical Pharmacology·A A AjayiJ L Reid
Jan 1, 1989·Pharmacotherapy·S L Chase, J D Sutton
May 1, 1988·Drug Intelligence & Clinical Pharmacy·G M Armayor, L M Lopez
Jan 1, 1987·Pharmacotherapy·M BorekW Frishman

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.